Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01294007 · ClinicalTrials.gov registry record · NA
Radiographic Analysis Using PureGen Versus Autologous Bone in Posterolateral Fusion (PLF)
A NA study, sponsored by Alphatec Spine.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT01294007: Clinical Trial NA study, sponsored by Alphatec Spine.
NCT01294007 is a NA study that was terminated before completion, run by Alphatec Spine. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01294007, a NA study, was terminated before completion, sponsored by Alphatec Spine.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the rate and quality of fusion of PureGen Osteoprogenitor Cell Allograft, compared to autograft bone in instrumented posterolateral fusion (PLF) procedures.
Primary Outcome
Number of patients with fusion at the 6- and conditional 12- and 24-month visit
Interventions
- BIOLOGICAL PureGen Osteoprogenitor Cell Allograft
- PROCEDURE Autograft bone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2011-02 |
| Est. Completion | 2013-11 |
| Phase | NA |
Why NCT01294007 stopped before completion
NCT01294007 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which PureGen Osteoprogenitor Cell Allograft is the first listed.
NCT01294007 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01294007 about?
NCT01294007 is a clinical study titled "Radiographic Analysis Using PureGen Versus Autologous Bone in Posterolateral Fusion (PLF)". The purpose of this study is to evaluate the rate and quality of fusion of PureGen Osteoprogenitor Cell Allograft, compared to autograft bone in instrumented posterolateral fusion (PLF) procedures.
What is the current status of trial NCT01294007?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2011-02. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01294007?
The interventions under investigation include: PureGen Osteoprogenitor Cell Allograft (BIOLOGICAL), Autograft bone (PROCEDURE).
Who is sponsoring clinical trial NCT01294007?
This trial is sponsored by Alphatec Spine, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01294007's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia